ArticleJCO global oncology2023
Spotlight on Human Papillomavirus Vaccination Coverage: Is Nigeria Making Any Progress?
Article in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Knowledge of human papilloma virus and vaccine hesitancy among health sciences students in Türkiye.Scientific reports · 2026Article
- HPV knowledge and willingness to receive HPV vaccine among female secondary school students in Ebonyi State, Nigeria: a pre-post evaluation of an educational intervention.BMC public health · 2026Article
- Article
- Emotional support networks and discussion of anal cancer among sexual minority men in Nigeria: insights from an ego-centric analysis.BMC public health · 2026Article
- Advancing the elimination of cervical cancer across Africa.Nature communications · 2026Review
- Early implementation and contextual determinants of the human papillomavirus vaccine rollout and uptake in Nigeria: a mixed-methods study.Frontiers in public health · 2026Article
- Gaps and barriers preventing sustained delivery of HPV vaccination in Kano, Kaduna, and Lagos states: An exploratory qualitative study.PloS one · 2026Article
- Human papillomavirus (HPV) vaccine clinical trials: A cross-sectional analysis of clinical trials registries.Human vaccines & immunotherapeutics · 2025Article
- Cervical cancer prevention and control in Nigeria: mapping and review of policies.Health policy and planning · 2025Review
- Article
- Predictors of willingness of HPV vaccine uptake across Eight States in Nigeria.BMC public health · 2025Article
- Intent to Receive Human Papillomavirus Vaccination among School-going Pre-teens and Adolescent Girls.International journal of MCH and AIDS · 2025Article
- Human papillomavirus (HPV) trials: A cross-sectional analysis of clinical trials registries.Human vaccines & immunotherapeutics · 2024Article
- HPV vaccine hesitancy among parents and caregivers of adolescents in Northern Nigeria.Vaccine: X · 2024Article
- Factors associated with HPV vaccine acceptance and hesitancy in Africa: a systematic review protocol.BMJ open · 2024Article
- The Past and Future of Inflammation as a Target to Cancer Prevention.Cancer prevention research (Philadelphia, Pa.) · 2024Article
- Determinants of Human Papillomavirus Vaccine Acceptance among Caregivers in Nigeria: A Fogg Behavior Model-Based Approach.Vaccines · 2024Article
- Knowledge, attitude, and uptake of HIV pre-exposure prophylaxis among students in tertiary institutions in Calabar Metropolis, Nigeria.Porto biomedical journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.